TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS

TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS

Provided herein are methods of treating diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases by administering to a mammal in need thereof a therapeutically effective amount of a compound of Formula I: in which B, R1, R1a, R2, R3, R4, R5, R6, R7, R10 and R11 have the meanings given in the spe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HICKEN ERIK JAMES, ROBINSON JOHN E, ALLEN SHELLEY, MUNSON MARK C, LYSSIKATOS JOSEPH P, HICKS JULIE MARIE, ZHAO QIAN, DELISLE ROBERT KIRK, MARMSATER FREDRIK P
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HICKEN ERIK JAMES
ROBINSON JOHN E
ALLEN SHELLEY
MUNSON MARK C
LYSSIKATOS JOSEPH P
HICKS JULIE MARIE
ZHAO QIAN
DELISLE ROBERT KIRK
MARMSATER FREDRIK P
description Provided herein are methods of treating diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases by administering to a mammal in need thereof a therapeutically effective amount of a compound of Formula I: in which B, R1, R1a, R2, R3, R4, R5, R6, R7, R10 and R11 have the meanings given in the specification.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2014045835A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2014045835A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2014045835A13</originalsourceid><addsrcrecordid>eNrjZDAOCfJ0jPL38Q-IDPJ08fRzVXD29w3wD_VzCVZwDFYI8PRV8Pb0cwx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoYmBiamFsamjobGxKkCAHBkKG4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS</title><source>esp@cenet</source><creator>HICKEN ERIK JAMES ; ROBINSON JOHN E ; ALLEN SHELLEY ; MUNSON MARK C ; LYSSIKATOS JOSEPH P ; HICKS JULIE MARIE ; ZHAO QIAN ; DELISLE ROBERT KIRK ; MARMSATER FREDRIK P</creator><creatorcontrib>HICKEN ERIK JAMES ; ROBINSON JOHN E ; ALLEN SHELLEY ; MUNSON MARK C ; LYSSIKATOS JOSEPH P ; HICKS JULIE MARIE ; ZHAO QIAN ; DELISLE ROBERT KIRK ; MARMSATER FREDRIK P</creatorcontrib><description>Provided herein are methods of treating diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases by administering to a mammal in need thereof a therapeutically effective amount of a compound of Formula I: in which B, R1, R1a, R2, R3, R4, R5, R6, R7, R10 and R11 have the meanings given in the specification.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140213&amp;DB=EPODOC&amp;CC=US&amp;NR=2014045835A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140213&amp;DB=EPODOC&amp;CC=US&amp;NR=2014045835A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HICKEN ERIK JAMES</creatorcontrib><creatorcontrib>ROBINSON JOHN E</creatorcontrib><creatorcontrib>ALLEN SHELLEY</creatorcontrib><creatorcontrib>MUNSON MARK C</creatorcontrib><creatorcontrib>LYSSIKATOS JOSEPH P</creatorcontrib><creatorcontrib>HICKS JULIE MARIE</creatorcontrib><creatorcontrib>ZHAO QIAN</creatorcontrib><creatorcontrib>DELISLE ROBERT KIRK</creatorcontrib><creatorcontrib>MARMSATER FREDRIK P</creatorcontrib><title>TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS</title><description>Provided herein are methods of treating diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases by administering to a mammal in need thereof a therapeutically effective amount of a compound of Formula I: in which B, R1, R1a, R2, R3, R4, R5, R6, R7, R10 and R11 have the meanings given in the specification.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAOCfJ0jPL38Q-IDPJ08fRzVXD29w3wD_VzCVZwDFYI8PRV8Pb0cwx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoYmBiamFsamjobGxKkCAHBkKG4</recordid><startdate>20140213</startdate><enddate>20140213</enddate><creator>HICKEN ERIK JAMES</creator><creator>ROBINSON JOHN E</creator><creator>ALLEN SHELLEY</creator><creator>MUNSON MARK C</creator><creator>LYSSIKATOS JOSEPH P</creator><creator>HICKS JULIE MARIE</creator><creator>ZHAO QIAN</creator><creator>DELISLE ROBERT KIRK</creator><creator>MARMSATER FREDRIK P</creator><scope>EVB</scope></search><sort><creationdate>20140213</creationdate><title>TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS</title><author>HICKEN ERIK JAMES ; ROBINSON JOHN E ; ALLEN SHELLEY ; MUNSON MARK C ; LYSSIKATOS JOSEPH P ; HICKS JULIE MARIE ; ZHAO QIAN ; DELISLE ROBERT KIRK ; MARMSATER FREDRIK P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2014045835A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>HICKEN ERIK JAMES</creatorcontrib><creatorcontrib>ROBINSON JOHN E</creatorcontrib><creatorcontrib>ALLEN SHELLEY</creatorcontrib><creatorcontrib>MUNSON MARK C</creatorcontrib><creatorcontrib>LYSSIKATOS JOSEPH P</creatorcontrib><creatorcontrib>HICKS JULIE MARIE</creatorcontrib><creatorcontrib>ZHAO QIAN</creatorcontrib><creatorcontrib>DELISLE ROBERT KIRK</creatorcontrib><creatorcontrib>MARMSATER FREDRIK P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HICKEN ERIK JAMES</au><au>ROBINSON JOHN E</au><au>ALLEN SHELLEY</au><au>MUNSON MARK C</au><au>LYSSIKATOS JOSEPH P</au><au>HICKS JULIE MARIE</au><au>ZHAO QIAN</au><au>DELISLE ROBERT KIRK</au><au>MARMSATER FREDRIK P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS</title><date>2014-02-13</date><risdate>2014</risdate><abstract>Provided herein are methods of treating diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases by administering to a mammal in need thereof a therapeutically effective amount of a compound of Formula I: in which B, R1, R1a, R2, R3, R4, R5, R6, R7, R10 and R11 have the meanings given in the specification.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2014045835A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A44%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HICKEN%20ERIK%20JAMES&rft.date=2014-02-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2014045835A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true